Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue. [electronic resource]
Producer: 20111027Description: 419-25 p. digitalISSN:- 0300-0664
- 11-beta-Hydroxysteroid Dehydrogenase Type 1 -- genetics
- Adrenocorticotropic Hormone -- blood
- Blood Glucose -- metabolism
- Enzyme Activation -- drug effects
- Gene Expression Regulation, Enzymologic -- drug effects
- Glucose Tolerance Test
- Humans
- Hydrocortisone -- blood
- Hyperglycemia -- drug therapy
- Hypoglycemic Agents -- administration & dosage
- Insulin -- blood
- Insulin Resistance -- physiology
- Liver -- drug effects
- Male
- Middle Aged
- Rosiglitazone
- Subcutaneous Fat -- drug effects
- Thiazolidinediones -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.